Testing a Low-Methionine Diet in Solid Tumor Patients
Part of Blood & lymphatic, Cancer, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This early-stage study explores whether eating a diet low in methionine (a natural amino acid found in protein) might help people with advanced solid tumors. Researchers will track how this dietary change affects blood levels and may improve treatment outcomes alongside standard cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a diagnosis of metastatic, recurrent, or unresectable solid tumor (cancer that has spread, returned, or cannot be surgically removed)
- Your doctor expects you to live at least 3 months
- You are well enough to tolerate cancer treatment (ECOG performance status 0–2, meaning you can care for yourself with minimal to moderate assistance)
- Your liver, kidney, and heart function are adequate based on recent blood tests
- You are willing and able to follow a low-methionine diet for the entire study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
This trial tests whether a special diet low in certain amino acids (building blocks of protein), combined with an immune-boosting antibody drug, can safely shrink stage III melanoma that has spread to lymph nodes. The goal is to see if this combination works better than standard treatment.
This study tests whether a special diet low in leucine (an amino acid) combined with chemotherapy and immunotherapy can safely treat advanced stomach cancer that has spread. Researchers want to see if this dietary approach helps the treatment work better and reduces side effects.
This study tests whether following a Mediterranean diet (rich in fruits, vegetables, whole grains, and healthy fats) can help improve outcomes for people newly diagnosed with early-stage breast cancer. If you're not already eating this way, you may be able to join and get guidance on making the switch.
This trial tests whether a special diet low in leucine (an amino acid) combined with chemotherapy and immunotherapy drugs can help treat locally advanced gastric cancer before surgery. The goal is to see if this combination is safe and more effective than standard treatment alone.
This trial tests if a diet low in leucine (an amino acid) can help treat gastric cancer before surgery. It aims to see if it's safe and effective for patients who are preparing for tumor removal.
Hear when a new Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.